INmune Bio Inc. (INMB) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
InmuneBio (INMB) Q1 2025: Alzheimer’s Addressable Market Expands to 70% on APOE4 Biomarker Shift
May 08, 2026
-
ImmuneBio (INMB) Q4 2025: Cordstrom Heads for 2026 Regulatory Filings as R&D Spend Drops 38%
March 31, 2026
-
ImmuneBio (INMB) Q3 2025: R&D Spend Down 52% as Cordstrom and XPro Advance Toward Regulatory Milestones
October 30, 2025
-
ImmuneBio (INMB) Q2 2025: $16.5M Asset Write-Off Signals Strategic Reset on ExPro Path
August 08, 2025